(S)-1-(2,2-DIETHOXYETHYL)-N-[2-(INDOL-3-YL)-ETHYL]-5-OXOPYRROLIDINE-2-CARBOXAMIDE
Compound with spectra: 1 NMR
![(S)-1-(2,2-DIETHOXYETHYL)-N-[2-(INDOL-3-YL)-ETHYL]-5-OXOPYRROLIDINE-2-CARBOXAMIDE](/api/compound/Kg9v3K2H37J.png?ph=true&h=300&w=458 "(S)-1-(2,2-DIETHOXYETHYL)-N-[2-(INDOL-3-YL)-ETHYL]-5-OXOPYRROLIDINE-2-CARBOXAMIDE")
| SpectraBase Compound ID | Kg9v3K2H37J |
|---|---|
| InChI | InChI=1S/C21H29N3O4/c1-3-27-20(28-4-2)14-24-18(9-10-19(24)25)21(26)22-12-11-15-13-23-17-8-6-5-7-16(15)17/h5-8,13,18,20,23H,3-4,9-12,14H2,1-2H3,(H,22,26)/t18-/m0/s1 |
| InChIKey | XTZKSGGKCALUIF-SFHVURJKSA-N |
| Mol Weight | 387.48 g/mol |
| Molecular Formula | C21H29N3O4 |
| Exact Mass | 387.215806 g/mol |
| Enantiomer InChIKey | XTZKSGGKCALUIF-GOSISDBHSA-N |
| Racemate InChIKey | XTZKSGGKCALUIF-UHFFFAOYSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CDCl3 |
Nb-(N-Z-Prolyl)tryptamine
ethanediamide, N~1~-[2-[[[2-(1H-indol-3-yl)ethyl]amino]carbonyl]phenyl]-N~2~-methyl-
ethanediamide, N~1~-(2-hydroxyethyl)-N~2~-[2-[[[2-(1H-indol-3-yl)ethyl]amino]carbonyl]phenyl]-
TRYPTAMINE-PHOSPHOPANTETHINE-BIS-[(PIVALOYLOXY)-METHYL]-ESTER;ENTRY-#7
N-[(E)-2-[4-(dimethylamino)phenyl]-1-({[2-(1H-indol-3-yl)ethyl]amino}carbonyl)ethenyl]benzamide
N-[(E)-1-({[2-(1H-indol-3-yl)ethyl]amino}carbonyl)-2-(4-methoxyphenyl)ethenyl]benzamide
1,2,4-oxadiazole-5-carboxamide, N-[2-(1H-indol-3-yl)ethyl]-3-(3-pyridinyl)-
2-thiophenecarboxylic acid, 3-[[2-[[2-(1H-indol-3-yl)ethyl]amino]-1,2-dioxoethyl]amino]-, methyl ester
N-[2-(1H-INDOL-3-YL)-ETHYL]-2-OXO-2-(3,4,5-TRIMETHOXYPHENYL)-ACETAMIDE
KEMLYAAGYMWIRH-FQHKDQSDSA-N
| Title | Journal or Book | Year |
|---|---|---|
| Synthesis of Enantiomeric Pure E-Nor-15-azayohimbines | Helvetica Chimica Acta | 1992 |